Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Oncology

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDS268PMID 22997451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

  2014cited by this paper
• Photodynamic therapy for management of cervical intraepithelial neoplasia II and III in young patients and obstetric outcomes

  2013cited by this paper
• Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging.

  2013cited by this paper
• Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.

  2013cited by this paper
• Simple Vaginal Trachelectomy in Early-Stage Low-Risk Cervical Cancer: A Pilot Study of 16 Cases and Review of the Literature

  2013cited by this paper
• Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

  2013cited by this paper
• Preventing Cancer with Vaccines: Progress in the Global Control of Cancer

  2012cited by this paper
• A randomized, phase III trial of paclitaxel plus carboplatin (TC) versus paclitaxel plus cisplatin (TP) in stage IVb, persistent or recurrent cervical cancer: Japan Clinical Oncology Group study (JCOG0505).

  2012cited by this paper
• Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.

  2012cited by this paper
• Laparoscopic, robotic and open method of radical hysterectomy for cervical cancer: A systematic review

  2012cited by this paper
• Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.

  2012cited by this paper
• 18F-FDG PET/CT of cervical carcinoma.

  2011cited by this paper
• Clinical Recommendation Radical Trachelectomy for Fertility Preservation in Patients With Early-Stage Cervical Cancer

  2011cited by this paper
• Radical Vaginal Trachelectomy (RVT) Combined With Laparoscopic Lymphadenectomy: Prospective Study of 225 Patients With Early-Stage Cervical Cancer

  2011cited by this paper
• Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience.

  2011cited by this paper
• Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.

  2011cited by this paper
• Excisional cone as fertility-sparing treatment in early-stage cervical cancer.

  2011cited by this paper
• Worldwide burden of cervical cancer in 2008.

  2011cited by this paper
• A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.

  2010cited by this paper
• Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer.

  2010cited by this paper
• Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.

  2010cited by this paper
• Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.

  2010cited by this paper
• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

  2009cited by this paper
• Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

  2009cited by this paper
• Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.

  2009cited by this paper
• A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

  2009cited by this paper
• HPV screening for cervical cancer in rural India.

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

  2009cited by this paper
• Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  2009cited by this paper
• Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.

  2009cited by this paper
• Chemotherapy for recurrent cervical cancer.

  2008cited by this paper
• Chemotherapy for recurrent and metastatic cervical cancer.

  2008cited by this paper
• Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.

  2008cited by this paper
• Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

  2007cited by this paper
• A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.

  2007cited by this paper
• Chemo-conization in early cervical cancer.

  2007cited by this paper
• Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

  2006cited by this paper
• A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.

  2006cited by this paper
• Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.

  2005cited by this paper
• Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

  2005cited by this paper
• Neoadjuvant chemotherapy for locally advanced cervix cancer.

  2004cited by this paper
• Relevance of chemotherapy dose and schedule to outcomes in ovarian cancer.

  2004cited by this paper
• Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  2004cited by this paper
• Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials.

  2003cited by this paper
• Neoadjuvant chemotherapy for locally advanced cervical cancer.

  2003cited by this paper
• Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.

  2002cited by this paper
• Guidelines for the treatment of recurrent and metastatic cervical cancer.

  2002cited by this paper
• A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  2001cited by this paper
• Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.

  2001cited by this paper
• Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.

  2001cited by this paper
• Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

  2000cited by this paper
• Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection.

  2000cited by this paper
• Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.

  2000cited by this paper
• Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.

  1999cited by this paper
• Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

  1999cited by this paper
• Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

  1999cited by this paper
• Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

  1999cited by this paper
• Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer.

  1998cited by this paper
• Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.

  1998cited by this paper
• Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.

  1997cited by this paper
• Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer.

  1997cited by this paper
• Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors.

  1997cited by this paper
• Radical surgery after induction chemotherapy in locally advanced cervical cancer. A feasibility study

  1994cited by this paper
• A possible new trend in the management of the carcinoma of the cervix uteri.

  1986cited by this paper
• Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study).

  1984cited by this paper

• The role of contact vaginal bleeding in cervical adenocarcinoma screening among young women

  2026cites this paper
• Automatic digitization of applicator and catheters for MRI-guided cervical cancer brachytherapy.

  2025cites this paper
• Capecitabine-Enhanced Brachytherapy in Locally Advanced Cervical Cancer: A Phase II Non-Randomized Trial on Safety and Efficacy

  2025cites this paper
• Excavation of Molecular Subtypes of Cervical Cancer Based on DNA Methylation Patterns.

  2025cites this paper
• The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?

  2025cites this paper
• Harnessing unsupervised machine learning with [18F]FDG PET/CT to develop a composite model for predicting overall survival in cervical cancer patients undergoing concurrent chemoradiotherapy

  2025cites this paper
• Real-World Data on Cervical Cancer: The Impact of 2020 COVID-19 Outbreak on the Treatment Patterns and Healthcare Resources Utilization in Brazilian Public Health System.

  2025cites this paper
• Advanced MRI prediction model for anatomical site identification in uterine carcinoma: enhancing diagnostic accuracy.

  2025cites this paper
• Role of HER-2/Neu Expression in Premalignant and Malignant Lesions of the Uterine Cervix: A Pathological Study

  2025cites this paper
• Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma

  2024cites this paper
• Mexican consensus about surgical treatment in early-stage cervicouterine cancer

  2024cites this paper
• GLA-loaded Liposome Albumin Particles-mediated p53 Targets Cervical Cancer Cell Transplant Tumors

  2024cites this paper
• Diagnostic assessments and treatment results of well-differentiated gastric-type adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter retrospective analysis of KROG 22-03 study.

  2024cites this paper
• Causes of death analysis and the prognostic model construction in neuroendocrine carcinoma of the cervix: A SEER‐based study

  2024cites this paper
• Multiparametric mri-based radiomics nomogram for predicting lymph-vascular space invasion in cervical cancer

  2024cites this paper
• Primary cervical malignant melanoma that was successfully treated with pembrolizumab: a case report and literature review

  2024cites this paper
• Current management of cervical cancer in women living with HIV.

  2024cites this paper
• Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system

  2024cites this paper
• Neoadjuvant chemotherapy followed by surgery versus concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma: a retrospective cohort study

  2024cites this paper
• Dual convolution-transformer UNet (DCT-UNet) for organs at risk and clinical target volume segmentation in MRI for cervical cancer brachytherapy

  2024cites this paper
• Efficacy and Diagnostic Reliability of Intraoperative Frozen Section in the Surgical Management of Early-Stage Cervical Cancer

  2024cites this paper
• Sarcoma of the uterine cervix: experience of a single center

  2024cites this paper
• MR Imaging of Gynecologic Tumors: Pearls, Pitfalls, and Tumor Mimics.

  2023cites this paper
• Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study.

  2023cites this paper
• Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix

  2023cites this paper
• Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing.

  2023cites this paper
• A systematic review of mucoadhesive vaginal tablet testing

  2023cites this paper
• Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016‐2018

  2023influential citation
• Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers

  2023cites this paper
• Corelaţii citologice, colposcopice şi histopatologice în diagnosticul neoplaziilor intraepiteliale cervicale

  2023cites this paper
• CBCT-based deformable dose accumulation of external beam radiotherapy in cervical cancer

  2023cites this paper
• Transcriptional Factors Targeting in Cancer Stem Cells for Tumor Modulation.

  2023cites this paper
• Vaginal microecological changes of different degrees of cervical lesions in Hakka women in Meizhou City

  2023cites this paper
• A nomogram-based optimized Radscore for preoperative prediction of lymph node metastasis in patients with cervical cancer after neoadjuvant chemotherapy

  2023cites this paper
• Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future

  2022cites this paper
• Anal Cancer in High-Risk Women: The Lost Tribe

  2022cites this paper
• Analysis of postoperative adjuvant therapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study.

  2022cites this paper
• Effect of MiR-10b on Cervical Cancer Rats Through mTOR/P70S6K Signaling Pathway.

  2022cites this paper
• The 1st Indonesian Society Gynecologic Oncology Scientific Meeting (INASMEET), November 12th to November 13th, 2022

  2022cites this paper
• A microfluidic chip using Au@SiO2 array–based highly SERS-active substrates for ultrasensitive detection of dual cervical cancer–related biomarkers

  2022cites this paper
• Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer.

  2022cites this paper
• Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial

  2022cites this paper
• Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells

  2022cites this paper
• Long-term Quality of Life and Sexual Function After Neoadjuvant Chemotherapy and Radical Surgery for Locally Advanced Cervical Cancer.

  2022cites this paper
• Early risk prediction of cervical cancer: A machine learning approach

  2022cites this paper
• Functioning metastasis from adrenocortical carcinoma

  2022cites this paper
• Bioactivity studies of two copper complexes based on pyridinedicarboxylic acid N-oxide and 2,2′-bipyridine

  2022cites this paper
• Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial

  2022cites this paper
• LncRNA FAM13A-AS1 Regulates Proliferation and Apoptosis of Cervical Cancer Cells by Targeting miRNA-205-3p/DDI2 Axis

  2022cites this paper
• Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?

  2022cites this paper
• Use of 18F-FDG PET CT for Evaluation of Rarely Seen Adenocarcinoma of Cervix Uteri Before and After Therapy

  2021cites this paper
• Fertility and Sexuality in Cancer Survivors

  2021cites this paper
• Overexpression of SMC4 predicts a poor prognosis in cervical cancer and facilitates cancer cell malignancy phenotype by activating NF-κB pathway

  2021cites this paper
• Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy.

  2021cites this paper
• Healthy-related quality of life in patients with cervical cancer in Southwest China: a cross-sectional study

  2021cites this paper
• Case Report: A Case Report and Literature Review on Severe Bullous Skin Reaction Induced by anti-PD-1 Immunotherapy in a Cervical Cancer Patient

  2021cites this paper
• Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).

  2021cites this paper
• Post-Conization FIGO stage IA1 squamous cell cervical carcinoma; is hysterectomy necessary?

  2021cites this paper
• Pap smear based cervical cancer detection using residual neural networks deep learning architecture

  2021cites this paper
• Therapeutic options for the management of cervical cancer

  2021cites this paper
• A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer

  2021cites this paper
• РАК ШЕЙКИ МАТКИ СТАДИЙ IB2–IIIB: НЕОАДЪЮВАНТНАЯ ХИМИОТЕРАПИЯ, РАДИКАЛЬНЫЕ ОПЕРАЦИИ И ВЫЖИВАЕМОСТЬ ПАЦИЕНТОВ

  2021cites this paper
• Cancer du col utérin : nouvelle classification de la Fédération internationale de gynécologie et d’obstétrique

  2021cites this paper
• Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?

  2021cites this paper
• Optimization of follow-up MRI protocol for malignant neoplasms of the female pelvis

  2021cites this paper
• Predicting factors for primary cervical cancer recurrence after definitive radiation therapy

  2021cites this paper
• Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018

  2021cites this paper
• Minimal-invasive or open approach for surgery of early cervical cancer: the treatment center matters

  2021cites this paper
• MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC

  2021cites this paper
• A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)

  2021cites this paper
• Assessment of cervical volume and spectral Doppler parameters in tumour dominant vessel of patients with locally advanced squamous cell cervical carcinoma

  2021cites this paper
• Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.

  2021cites this paper
• Interstitial brachytherapy for gynecologic malignancies: Complications, toxicities, and management.

  2021cites this paper
• A rare case of post radiation urinary bladder necrosis in a patient with carcinoma cervix

  2021cites this paper
• MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells

  2021cites this paper
• Clinical relevance of addition of conventional treatment to concurrent chemoradiotherapy in patients with FIGO stage III-IV cervical cancer: a retrospective analysis of a Japanese cohort.

  2021cites this paper
• Clinical significance of kinesin family member 2A as a facilitating biomarker of disease surveillance and prognostication in cervical cancer patients

  2021cites this paper
• OVERVIEW OF ARTIFICIAL INTELLIGENCE IN CERVICAL CANCER SCREENING BY CYTOLOGY

  2021cites this paper
• Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data

  2021cites this paper
• Comparison of no adjuvant treatment and radiotherapy in early‐stage cervical carcinoma with intermediate risk factors

  2020cites this paper
• The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions

  2020cites this paper
• Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix

  2020cites this paper
• T-Staging and Target Volume Definition by Imaging in GYN Tumors

  2020cites this paper
• Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.

  2020cites this paper
• Predictive Role of MRI and 18F FDG PET Response to Concurrent Chemoradiation in T2b Cervical Cancer on Clinical Outcome: A Retrospective Single Center Study

  2020cites this paper
• Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey

  2020cites this paper
• Analysis of the effects of mEHT on the treatment-related toxicity and quality of life of HIV-positive cervical cancer patients

  2020cites this paper
• Post-conization cervical stenosis treated with silicone catheter in microinvasive cervical cancer patient: A case report

  2020cites this paper
• Aldehyde dehydrogenase 1, a target of miR-222, is expressed at elevated levels in cervical cancer

  2020cites this paper
• Hsa_circ_103973 Acts as a Sponge of miR-335 to Promote Cervical Cancer Progression

  2020cites this paper
• Challenges and advances in cervix cancer treatment in elder women.

  2020cites this paper
• Mucoepidermoid Carcinoma of the Uterine Cervix—Single-Center Study Over a 10-Year Period

  2020cites this paper
• Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence

  2020cites this paper
• The association between the use of traditional Chinese medicine and mortality among cervical cancer patients: A large-scale retrospective cohort study

  2020cites this paper
• miR-96 enhances the proliferation of cervical cancer cells by targeting FOXO1.

  2020cites this paper
• Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: a retrospective observational study

  2020cites this paper
• HPV-16/18 pozitif kadınların takibinde kolposkopi eşliğinde alınan servikal biyopsinin önemi

  2020cites this paper
• Experience of using Colon View test in colorectal cancer screening program for liquidators of Chernobyl accident’s consequences

  2020cites this paper
• Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer

  2020cites this paper
• Molecular landscape of recurrent cervical cancer.

  2020cites this paper